Structural simulation and selective inhibitor discovery study for histone demethylases KDM4E/6B from a computational

Chenxiao Wang1, Baichun Hu2, Yi Yang1

  • 1Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China; School of Pharmacy, Shenyang Pharmaceutical University, Benxi 117004, China.

Summary

Histone lysine demethylases (KDMs) like KDM4E and KDM6B regulate gene expression and disease. Selective inhibitors reveal distinct binding interactions, offering new therapeutic targets for cancer and aging.